Browse drugs

…n T1D pathogenesis, including therapeutic B cell depletion with rituximab, which preserved beta-cell function for 1 year,38 and variation…

…tive exercise prescription compared with traditional outpatient Schroth therapy.Methods and analysis This parallel-group randomised con…

…etermine whether a single intraoperative subanaesthetic dose of esketamine, as an adjunct to antidepressant therapy, improves postoperativ…

…rtion of neonates receiving parenteral nutritional support with 10% dextrose and amino acids increased from 18.5% to 66.1% between the pre- …

…tion HR (sHR) 2.23, 95% CI 1.10 to 4.52, p=0.027), while higher MELD-Na reduced its likelihood (sHR 0.91, 95% CI 0.86 to 0.97, p=0.006)…

… binds to MOXD1 and blocks its interaction with ACOX1. Notably, rM15 robustly protected against hepatocyte lipid accumulation and su…

…ction against metastatic spread in the MSTO-211H model, whereas doxorubicin overcomes TRAIL resistance rendering the A549 model more suscep…

…es occurrence of Dose-limiting Toxicities in patients receiving TR006. Further data from blood tests, endomyocardial biopsy tissue, c…

…nicable diseases. Most uncomplicated infections respond to oral ivermectin or oral praziquantel, which are easy to take and generally well…

…e backbone of front-line therapy for most patients with cancer. Immune checkpoint inhibitors, T cell engagers, and adoptive cell therapies have traditionall…

…isoproxil fumarate/emtricitabine in all age groups. Long-acting cabotegravir was used more often with increasing age (9.8% in <50, 11.5% in …

…Introduction The long-acting injectable dual therapy cabotegravir + rilpivirine improves quality of life and adherence in virolog…